Exploring the Relationship Between Comorbidities and Prolonged Viral Shedding in COVID‐19: A Cycle Threshold Value‐Based Investigation
Canadian Journal of Infectious Diseases and Medical Microbiology · 2026-01 · 2026 (1)
DOI: 10.1155/cjid/8871861 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Infectious Diseases and Medical Microbiology, online erschienen am 12.05.2026. Verfasst von Rudi Wisaksana und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Tropical and Infectious Disease, Department of Internal Medicine, Faculty of Medicine Universitas Padjadjaran, Hasan Sadikin General Hosp…. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
We aim to investigate which of the comorbidities is associated with prolonged viral RNA shedding among hospitalized patients with COVID‐19 illness. Patients and Methods We conducted a retrospective cohort study of COVID‐19 patients in Hasan Sadikin General Hospital, Bandung, from March 2020 to April 2022. Data of ORF1b Ct value measurements were collected from the 1 st week to the 5 th week and presented in a line plot to see the changes in the Ct values across the course of the disease stratified to each comorbidity.
Results
We included a total of 279 patients with a median age of 55‐year‐old, and male patients were the majority included. However, 68% of the original cohort was excluded due to having only a single Ct result. Based on the ORF1b Ct value data, most patients within each comorbidity group demonstrated increasing Ct values from Week 1 ( n = 135) to Week 5 ( n = 34). However, we found that the ORF1b Ct value in the HIV–AIDS ( n = 12) and the autoimmune ( n = 12) groups peaked and gradually declined. In the HIV–AIDS ORF1b, Ct values declined after 2 weeks ( n = 2) with a statistically significant difference compared to patients without comorbidity ( n = 65).
Conclusion
This study shows that COVID‐19 patients with HIV–AIDS have prolonged viral shedding compared to patients with other comorbidities.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Tropical and Infectious Disease, Department of Internal Medicine, Faculty of Medicine Universitas Padjadjaran, Hasan Sadikin General Hospital, Bandung, Indonesia.
- Department of Internal Medicine, Faculty of Medicine Universitas Padjadjaran, Hasan Sadikin General Hospital, Bandung, Indonesia.
- Department of Clinical Pathology, Faculty of Medicine Universitas Padjadjaran, Hasan Sadikin General Hospital, Bandung, Indonesia.
- Division of Pulmonology and Critical Illness, Department of Internal Medicine, Faculty of Medicine Universitas Padjadjaran, Hasan Sadikin General Hospital, Bandung, Indonesia.
ORCID-Profile: Rudi Wisaksana, Chrisan Bimo Prayuda, Evan Susandi
Zitieren
APA
Wisaksana, R., Philo, P., Putri, F. I., Prayuda, C. B., Susandi, E., Widyatmoko, L., Alisjahbana, B., Kulsum, I. D., & Hartantri, Y. (2026). Exploring the Relationship Between Comorbidities and Prolonged Viral Shedding in COVID‐19: A Cycle Threshold Value‐Based Investigation. Canadian Journal of Infectious Diseases and Medical Microbiology, 2026(1). https://doi.org/10.1155/cjid/8871861
Vancouver
Wisaksana R, Philo P, Putri FI, Prayuda CB, Susandi E, Widyatmoko L, et al. Exploring the Relationship Between Comorbidities and Prolonged Viral Shedding in COVID‐19: A Cycle Threshold Value‐Based Investigation. Canadian Journal of Infectious Diseases and Medical Microbiology. 2026;2026(1). doi:10.1155/cjid/8871861
BibTeX
@article{Wisaksana2026,
author = {Wisaksana, Rudi and Philo, Patrick and Putri, Floriyani Indra and Prayuda, Chrisan Bimo and Susandi, Evan and Widyatmoko, Leonardus and Alisjahbana, Bachti and Kulsum, Iceu Dimas and Hartantri, Yovita},
title = {Exploring the Relationship Between Comorbidities and Prolonged Viral Shedding in COVID‐19: A Cycle Threshold Value‐Based Investigation},
journal = {Canadian Journal of Infectious Diseases and Medical Microbiology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/cjid/8871861}
}
EUVIMED